By seamlessly combining a variety of molecular technologies, diagnostic kit manufacturing ... and centralized laboratory testing for clinical assessment and commercialization—Bio-Techne has ...
Bio-Techne Corporation announced that Asuragen, a Bio-Techne brand, launched a highly sensitive ESR1 mutation monitoring assay. ESR1 gene mutations are known to be linked to hormone receptor-positive ...
Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a ...